Seth A

References (9)

Title : Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease - Choubey_2021_Bioorg.Chem_111_104922
Author(s) : Choubey PK , Tripathi A , Tripathi MK , Seth A , Shrivastava SK
Ref : Bioorg Chem , 111 :104922 , 2021
PubMedID: 33945941

Title : Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer's disease - Tripathi_2020_J.Comput.Aided.Mol.Des__
Author(s) : Tripathi MK , Sharma P , Tripathi A , Tripathi PN , Srivastava P , Seth A , Shrivastava SK
Ref : J Comput Aided Mol Des , : , 2020
PubMedID: 32488355

Title : Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease - Sharma_2019_Eur.J.Med.Chem_167_510
Author(s) : Sharma P , Tripathi A , Tripathi PN , Prajapati SK , Seth A , Tripathi MK , Srivastava P , Tiwari V , Krishnamurthy S , Shrivastava SK
Ref : Eur Journal of Medicinal Chemistry , 167 :510 , 2019
PubMedID: 30784883

Title : Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease - Tripathi_2019_Bioorg.Chem_95_103506
Author(s) : Tripathi A , Choubey PK , Sharma P , Seth A , Saraf P , Shrivastava SK
Ref : Bioorg Chem , 95 :103506 , 2019
PubMedID: 31887472

Title : Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions - Tripathi_2019_Bioorg.Med.Chem_27_1327
Author(s) : Tripathi PN , Srivastava P , Sharma P , Seth A , Shrivastava SK
Ref : Bioorganic & Medicinal Chemistry , 27 :1327 , 2019
PubMedID: 30795991

Title : Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies - Sharma_2019_Prog.Neurobiol_174_53
Author(s) : Sharma P , Srivastava P , Seth A , Tripathi PN , Banerjee AG , Shrivastava SK
Ref : Prog Neurobiol , 174 :53 , 2019
PubMedID: 30599179

Title : Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease - Tripathi_2019_Eur.J.Med.Chem_183_111707
Author(s) : Tripathi A , Choubey PK , Sharma P , Seth A , Tripathi PN , Tripathi MK , Prajapati SK , Krishnamurthy S , Shrivastava SK
Ref : Eur Journal of Medicinal Chemistry , 183 :111707 , 2019
PubMedID: 31561043

Title : Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions - Mishra_2019_Bioorg.Chem_89_103025
Author(s) : Mishra P , Sharma P , Tripathi PN , Gupta SK , Srivastava P , Seth A , Tripathi A , Krishnamurthy S , Shrivastava SK
Ref : Bioorg Chem , 89 :103025 , 2019
PubMedID: 31176239

Title : Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory - Tripathi_2018_Bioorg.Chem_85_82
Author(s) : Tripathi PN , Srivastava P , Sharma P , Tripathi MK , Seth A , Tripathi A , Rai SN , Singh SP , Shrivastava SK
Ref : Bioorg Chem , 85 :82 , 2018
PubMedID: 30605887